Molecular genetic analyses have clari®ed that accumulation of genomic changes provides important steps in carcinogenesis and have identi®ed a number of valuable genetic markers for certain cancers. To date, however, no prognostic markers have been identi®ed for hepatocellular carcinoma (HCC). In this study, we used restriction landmark genomic scanning (RLGS), a new high-speed screening method for multiple genomic changes, to detect unknown genetic alterations in HCC. Thirty-one HCC samples and their normal counterparts were examined by RLGS. Eight spot changes were common in several cases, and all were seen only on the HCC pro®le. Five of these spots were detected in more than 12 of 31 cases (38.7%). Viral infection had no in¯uence on changes in the RLGS spots. The disease-free survival rate for patients with 516 changed RLGS spots was signi®cantly lower than that for patients with fewer changed RLGS spots (415 spots) (P50.001). In multivariate analysis, the number of changed spots was proven to retain an independent prognostic value (relative risk 1.095: P=0.0031). These results suggest that the number of changed RLGS spots may be a useful biological marker for recurrence of HCC.
Introduction
Several factors have been used for predicting the postoperative recurrence of hepatocellular carcinoma (HCC). As for tumor factors, tumor size, portal venous invasion, and intrahepatic metastasis are reportedly related signi®cantly to recurrence (Belghiti et al., 1991; Jow et al., 1992; Hsu et al., 1988; Arii et al., 1992; Sirabe et al., 1991) . However, recurrence is not rare in cases with small HCC having neither portal venous invasion nor intrahepatic metastasis (Sirabe et al., 1991) . On the other hand, liver function data and the level of liver cirrhosis have been used as prognostic markers for postoperative recurrence (Lise et al., 1998; Kubo et al., 1998) because continuous necrosis and regeneration of hepatocytes in chronic hepatitis, which leads to liver cirrhosis, is thought to promote accumulation of genomic aberrations associated with hepatocarcinogenesis (Takayama et al., 1990; Kew and Popper, 1984) and HCC is generated multicentrically (Tsuda et al., 1998; Hsu et al., 1991) . However, we have often experienced HCC without liver dysfunction and cirrhosis that recurs very rapidly, as well as HCC with severe cirrhosis that does not recur for a long time.
Molecular genetic analyses have identi®ed a number of genetic markers that are closely correlated with the clinical characteristics of certain cancers (Kinoshita et al., 1995; Kitagawa et al., 1996) . Despite extensive study, however, no genetic markers for recurrence of HCC have been discovered to date (Himeno et al., 1988; Zhang et al., 1987) .
Restriction landmark genomic scanning (RLGS) was developed as a high-speed screening method for multiple genomic changes (Hatada et al., 1991) . In RLGS, genomic DNA is digested with speci®c restriction enzymes and then subjected to direct isotopical end-labeling at the restriction sites. These end-labeled restriction fragments are separated by twodimensional electrophoresis and detected as discrete spots on an RLGS pro®le. The intensity of each spot represents the copy number of the fragments, allowing more than 2500 loci on the genome to be analysed in one procedure with no probes or primers. Therefore, RLGS is suitable for the detection of many unknown genomic DNA aberrations that may accumulate in a tumor (Miwa et al., 1995 (Miwa et al., , 1996 Costello et al., 1997) .
In the present study, we used RLGS to detect genetic alterations in HCC and examined the correlation between postoperative recurrence and the number of genetic alterations.
Results

RLGS profiles
Each RLGS pro®le has about 2500 spots that represent the corresponding loci of genomic DNA (Figure 1 ). It is highly reproducible and each spot appears at the same position on the pro®le each time. We examined about 1200 spots.
The intensity levels of all 1214 spots in case N1 were measured ( Figure 2 ). All spots were divided into several peaks. The minimum peak (a) consisted of 477 spots (39.4%; 1500 ± 3000 pixel value6inches 2 ) and the second peak (b), the intensity of which was twofold higher than that of the a peak, consisted of 492 spots (40.5%; 4000 ± 5500 pixel value6inches 2 ). The other peaks all had the integral intensity of the a peak.
Differences among individuals
The RLGS spots of ®ve noncancerous liver tissues with neither hepatitis B virus (HBV) nor hepatitis C virus (HCV) infection (control group) were compared (Table  1) . In total, 1187 spots (98%) were common to all ®ve samples. Most spots that diered among individuals (24.2 spots; 2%) were common in multiple cases. Except appearing and disappearing spots, all dierences in spot intensity among individuals corresponded to an almost twofold increase from the a to the b peak or a 50% decrease from the b to the a peak, as shown in Figure 2 .
The influence of viral infection on the genome in noncancerous tissue
Noncancerous tissues were compared within the control group, between the control and HBV groups, and between the control and HCV groups (Figure 3) . The average number of dierent spots within the control group was 23.2. The average dierence in the number of spots between the control and HBV groups was 24.0, and between the control and HCV groups 21.4. None of these dierences were signi®cant. Furthermore, no spots were limited to the HBV or HCV group. The changes seen in spots were disappearance, appearance and intensity dierences between a and b peaks, as shown in Figure 2 . Genomic DNA was extracted from each sample and 3.5 mg of DNA were used for restriction landmark genomic scanning. The DNA, cleaved by NotI and end-labeled, was digested with PvuII, electrophoresed in the ®rst dimension, and then digested in situ with PstI, followed by another round of electrophoresis in the second dimension. The separated DNA fragments were visualized autoradiographically. Every pro®le has about 2500 spots that represent corresponding loci of genomic DNA. About 1200 spots in the square were examined Figure 2 Histogram of the density of all spots in one RLGS pro®le. The densities of 1214 spots, all the spots in the RLGS pro®le of case N1, were measured by NIH image as the mean pixel value by the area of the spot (inches 2 ) and were shown in a histogram. All spots were divided into several peaks. The minimum peak (a) accounted for 39.4% of all spots (1500 ± 3000 pixel value6inches 2 ) and the second peak (b) for 40.5% of spots (4000 ± 5500 pixel value6inches 2 ). The other peaks all had an integral density equal to that of the a peak Figure 3 The number of dierent RLGS spots among individual noncancerous tissues. Comparisons were made between each of ®ve pairs of noncancerous tissues in the control group, between the control and HBV groups, and between the control and HCV group. The number in parentheses is the number of spots present on both sides but the density exceeds that of the corresponding spot on the other side. The average number of dierent spots within the control group was 23.2, between the control and HBV groups 24.0, and between the control and HCV groups 21.4. No signi®cant dierences were detected in these three comparisons
Difference between HCC and normal liver tissue
We compared RLGS pro®les between HCC and the surrounding noncancerous liver tissue (Figure 4 ). Eight spot changes were common in several cases, and all of these spots were only seen on the HCC pro®le. Five of these spots were detected in more than 12 of 31 cases (38.7%), shown as spots A ± E in Figure  4 . Spot A was detected in 20 of 31 cases (64.5%). All changed spots between HCC and noncancerous liver tissue were dierent from the dierent spots in Table 1 and Figure 3 .
The correlation of RLGS spot changes in hepatocarcinogenesis with viral infection was examined. The numbers of changed spots were compared among three groups; the nonBnonC, HBV and HCV groups ( Figure  5 ). The HBV and HCV group had signi®cantly more changed spots than the nonBnonC group. There were no signi®cant dierences in the number of changed spots between the HBV and HCV groups, but in the HCV group the frequencies of spots varied widely, whereas in the HBV group the numbers of spots could be divided into two types, many (30 ± 40 spots) in four cases and a few (0 ± 5 spots) in four cases.
The relations between the number of RLGS spots and the clinicopathological features were examined. Among host factors and test values including sex, age, total bilirubin, serum alanine aminotransferase, serum asparatate aminotransferase, albumin, prothrombin activity, total protein, cholinesterase, total cholesterol, zinc sulfate turbidity test, indocyanine green (ICG) retention test, level of liver cirrhosis and the Clinical Stage Grouping of Classi®cation of Primary Liver Cancer by the Liver Cancer Study Group of Japan (1997), only albumin (Pearson's correlation coecient; 0.368, P=0.041) and total cholesterol (0.369, P=0.044) were signi®cantly correlated with the number of changed RLGS spots in all patients. There was also a trend indicating decreased liver function with increased number of changed spots in terms of other host factors, but this trend did not reach statistical signi®cance. As for tumor factors including number of tumors, tumor size, histological grading of the HCC tissue, growth type, capsule formation, capsule in®ltration, serosa invasion, vascular and bile duct invasion, and intrahepatic metastasis, and the Stage Grouping of Classi®cation of Primary Liver Cancer by the Liver Cancer Study Group of Japan, none of these factors were correlated with the number of changed RLGS spots.
The correlation of RLGS spots with postoperative prognosis was examined. When HCC patients were grouped according to number of changed RLGS spots (Table 2) , they could be largely classi®ed into two groups based on the RLGS pro®le and postoperative recurrence. One group had numerous changed spots, most notable spots A ± E, and recurrence. The other group had only a few changed spots and no recurrence. Patients were divided into two groups on the basis of number of changed RLGS spots, a major change Figure 4 Dierence between HCC and normal surrounding tissue (case C1). We compared the RLGS pro®les of HCC and normal surrounding liver tissue from the same patient. Large arrows indicate the spots appearing on only one side of the two pro®les, small arrows the spots with greater density than the corresponding spot on the other side. Eight spots were changed in several cases, all in the HCC pro®le. Five of these spots were detected in more than 12 of 31 cases (38.7%), shown as spots A ± E. Spot A was detected in 64.5% of cases Figure 5 The relation of RLGS spot change to viral infection. The numbers of changed spots were compared among the nonBnonC, HBV and HCV groups. Each point with a bar represents the mean+s.d. of the number of changed spots. The HBV and HCV groups had signi®cantly more changed spots than the nonBnonC group. There were no signi®cant dierences in average number of changed spots between the HBV and HCV groups. In the HCV group the number varied widely, however, whereas in the HBV group the numbers could be divided into two types, many (30 ± 40 spots) in four cases and a few (0 ± 5 spots) in two cases. *Fisher's PLSD P50.05
New predictive factor for hepatocellular carcinoma O Itano et al group which had equally more than 16 changed spots and a minor change group which had less than 16 changed spots. The crude survival rate could not be examined because only four patients had died. The postoperative recurrence rate was compared between these two groups ( Figure 6A ). The disease-free survival rate of the major change group was signi®cantly lower than that of the minor change group. When clinicopathological background factors (host and tumor factors) were compared between the two groups, there was a signi®cant dierence only in glutamic pyruvic transaminase (Glutamic pyruvic transaminase was higher in the major than in the minor change group. Student's t-test; P=0.027). When type of recurrence was examined, there were multiple intrahepatic recurrences in most cases and there was no signi®cant dierence between the two groups. Postoperative recurrence rates were compared between these two groups in patients without portal venous invasion at operation ( Figure 6B ), in patients with tumor diameters of 3 cm or less ( Figure 6C ) and in patients with a single tumor ( Figure 6D ). The disease-free survival rates of the major change group were also signi®cantly lower than those of the minor change group. The prognostic value of the number of changed RLGS spots and other clinicopathological background factors (the host and tumor factors described above) were assessed by univariate analysis. Portal venous invasion (relative risk 2.315: P=0.0051) and the number of changed RLGS spots (relative risk 1.065: P=0.006) emerged as signi®cant prognostic factors. We performed multivariate analysis with the number of changed RLGS spots and certain conventional factors, i.e. Clinical Stage (representing liver function) of the Classi®cation of Primary Liver Cancer by the Liver Cancer Study Group of Japan, portal venous invasion, age and sex. The number of changed RLGS spots emerged as an independent prognostic factor ( Table 3) .
Discussion
In this study, genetic alterations associated with hepatocarcinogenesis were analysed by RLGS and a group of HCC patients at high risk for postoperative recurrence was identi®ed.
Alterations in RLGS spots can indicate several types of genomic changes. Loss or appearance of a spot indicates deletion, or mutation, of a gene. In addition, it may also mean changes in the regulation of protein production by methylation or demethylation, since NotI is a methylation-sensitive enzyme and over 80% of NotI sites are believed to lie in CpG islands (Lindsay and Bird, 1987 ). An increase in the intensity of a spot may mean gene ampli®cation or demethylation of another allele or repeat sequence, whereas a decrease in intensity indicates allelic changes or methylation of one allele or some part of a repeat sequence. Thus, any change in an RLGS spot means genetic alteration and the number of changed RLGS spots re¯ects the level of genetic instability. The densities of spots on RLGS pro®les were divided into several peaks and these peaks were all multiples of the minimum peak, termed a, as shown in Figure 2 . The intensity of an RLGS spot re¯ects the gene copy number, such that the minimum (a) peak may indicate a haploid level and the second peak, b, which comprises most of RLGS spots, may indicate a diploid level. It has already been reported that RLGS can detect low-level ampli®cation and even loss of heterozygosity (Ohsumi et al., 1995b; Hirotsune et al., 1992) . Our data show that RLGS can even distinguish each genomic change at the one copy number level.
In the present study, RLGS showed that there is a 2% genetic dierence among individuals (Table 1) . Most dierent spots were seen in several cases and in only one individual were there only a few spots. The dierences in intensity all indicated haploid and diploid states. These results suggested that most genetic dierences among individuals were promoted through change of one allele to the next generation.
To clarify the in¯uence of viral infection on the genome in noncancerous tissue, genomic dierences among the control, HBV and HCV groups were examined by RLGS. There were no signi®cant dierences in spot changes among the three groups. Furthermore, as shown in Figure 3 , the dierence in number of spots between each two groups was nearly the same as the dierence between individuals in the control group (Table 1) . This showed that viral infections have little in¯uence on changes in RLGS spots in noncancerous tissue. However, the possibility that viral infections promote genomic aberrations cannot be ruled out. It is an important feature of RLGS that it shows only genomic aberrations common to most cells in a sample as spot changes, i.e. genomic changes in a small portion of cells may be undetectable. The genomic aberrations produced by viral infection were random in each cell and were not the same in all noncancerous cells. Therefore, this approach may not detect the in¯uence of viral infection but rather only dierences among individuals, as shown in Figure 3 and Table 1 The number of genomic aberrations in HCC was directly measured as the number of changed spots by RLGS and was found to be more signi®cantly correlated with postoperative recurrence than the conventional factors used for predicting postoperative recurrence of HCC. Portal venous invasion is another signi®cant factor, which has already been recognized as having prognostic value (Arii et al., 1992; Sirabe et al., 1991) . However the recurrence rate within 5 years for the cases without portal venous invasion was reported over 50% (Arii et al., 1992) . The number of changed spots was signi®cant even in cases without portal venous invasion ( Figure 6B ). Furthermore, tumor diameter and intrahepatic metastasis, which are representative conventional factors (Belghiti et al., 1991; Jow et al., 1992; Hsu et al., 1988; Arii et al., 1992; Sirabe et al., 1991) , as shown in Figure 6C ,D, had no in¯uence. Therefore, the number of changed RLGS spots was more useful as a new genetic marker, for predicting postoperative recurrence of HCC, than conventional factors.
Currently, nonBnonC HCC and HBV-related HCC are thought to recur less often and to have a better prognosis than HCV-related HCC at the same Stage (Yamanaka et al., 1997) . However, we have often experienced HBV-related HCC that recurs immediately after curative resection. In RLGS, the majority of nonBnonC HCCs had few changed spots whereas HCV-related HCCs had many changed spots, and HBV-related HCCs could be divided into two types. This heterogeneity of HBV-related HCCs is consistent with our previous experience. These results show that the mechanisms by which each virus generates hepatocarcinogenesis dier, though a common HCC pathway was suggested because of the existence of changed RLGS spots common to the HBV, HCV and nonBnonC groups. Furthermore, there were no changed spots speci®c to any one virus. In addition, the number of changed RLGS spots was signi®cantly correlated with postoperative recurrence of HCC regardless of virus type.
Two hypotheses may explain the number of RLGS spots being signi®cantly correlated with postoperative recurrence. The number of RLGS spots may represent the potential for carcinogenesis of adjacent noncancerous tissue. Changed RLGS spots in the HCC pro®le indicate genomic aberrations already present in noncancerous cells as well as additional genomic changes associated with carcinogenesis. Therefore, HCC with more changed RLGS spots is surrounded by a background of noncancerous liver parenchyma with more genomic aberrations and is thus more likely to recur because the noncancerous tissue has a high potential for carcinogenesis. This type of recurrence is multicentric.
Alternatively, the malignancy of HCC increases with the number of genetic changes. Therefore, HCC with numerous changed RLGS spots is more likely to recur. This recurrence is in the form of metastasis. Variables related to tumor invasiveness, such as vascular invasion or intrahepatic metastasis, are considered to possibly be related to the number of changed spots, as shown in Table 2 , though the relation is not statistically signi®cant. Most recurrent disease in this study was multiple intrahepatic recurrence, which could not be distinguished from multicentric development or intrahepatic metastasis. However, in addition to taking the observation period of 18 months into consideration, a major portion of multiple intrahepatic recurrences can reasonably be regarded as intrahepatic metastasis. This is true despite multiple intrahepatic recurrences being detected in most recurrent cases. Therefore, the latter can be more easily understood than the former. In any event, the number of changed RLGS spots is useful for predicting postoperative recurrence even in the patients shown in Figure 6B ,C,D, who were not previously recognized as belonging to a high risk group.
We found only ®ve RLGS spots in HCC pro®les that were common to 38.7% of cases. In particular, spot A was common to 64.5%. One of the advantages of RLGS is that DNA fragments can be cloned from the spots (Miwa et al., 1995 (Miwa et al., , 1996 Costello et al., 1997; Hirotsune et al., 1993; Ohsumi et al., 1995a) . In an eort to characterize the genomic changes corresponding to spots associated with HCC, cloning studies are now in progress.
In conclusion, the dierence in the number of changed RLGS spots between noncancerous liver tissue and HCC was signi®cantly correlated with postoperative recurrence of HCC. This is because these spot changes represent genetic changes associated with hepatocarcinogenesis more directly and accurately than conventional methods. A useful marker for the prognosis of HCC has not been identi®ed to date. RLGS is anticipated to be the ®rst prognostic marker for HCC and to facilitate preoperative diagnosis and postoperative therapy.
Materials and methods
Patients and specimens
A total of 31 patients with primary HCC (mean age, 59 years; range, 35 ± 72 years; 29 males and two females) who had undergone curative hepatectomies at Keio University Hospital (Tokyo, Japan) between May 1995 and December 1997 were studied. Samples for DNA extraction were obtained from primary HCC tissue and adjacent noncancerous tissue from the resected liver, and all samples were kept frozen at 7708C until DNA preparation.
The clinocopathological background factors of the patients were assessed according to the Classi®cation of Primary Liver Cancer; ®rst English edition of the Liver Cancer Study Group of Japan. Patients were followed every 3 months in the outpatient clinic. Recurrences were diagnosed based on ®ndings at reoperation, autopsy and/or diagnostic imagings, including routine total body computed tomography, magnetic resonance imaging and ultrasonography. The maximum observation period was 31 months and the mean observation period was 18 months.
Eight patients were hepatitis B surface antigen positive and hepatitis C antibody negative (HBV group: cases B1 ± B8), 15 patients were hepatitis B surface antigen seronegative and hepatitis C antibody seropositive (HCV group: cases C1 ± C15), and eight patients were both hepatitis B surface antigen and hepatitis C antibody seronegative (nonBnonC group: cases NBNC1 ± NBNC8) based on serological tests.
Five noncancerous liver tissues without hepatitis virus infection, resected for liver metastasis of colon cancer, were used as a control (control group: cases N1 ± N5).
DNA preparation and RLGS
High molecular weight genomic DNA was isolated from all samples (Blin and Staord, 1976) . RLGS was performed according to published protocols (Hatada et al., 1991) . Brie¯y, genomic DNA was digested with NotI and PvuII restriction enzymes, and the NotI derived 5' protruding ends were 32 P-labeled. After ®rst dimension separation of fragments in agarose disc gels, a second digestion was done in situ with PstI. The resulting fragments were separated perpendicularly in a polyacrylamide gel. The separated DNA fragments were visualized by autoradiography.
Analysis
RLGS pro®les were digitalized on a VXR-8 Digitizer (Vidar Systems Corporation, Hendon, VA, USA) and the positions and intensities of spots were analysed on a Macintosh computer (System 7.5; Apple Computer Inc., CA, USA) with Adobe Photoshop 2 3.0J (Adobe Systems Incorporated, CA, USA) and NIH image (NIH's Division of Computer Research and Technology, MD, USA). The positions of RLGS spots against the surrounding spots were examined visually and the intensity of spots was measured as the pixel value6inches 2 on the NIH image. When the intensities of spots were compared among multiple pro®les, the relative intensity against the surrounding ®ve spots without change was used. If the intensity dierence between two spots was equal to more than of one copy level, these spots were regarded as a`dierent spot' or a`changed spot'.
Statistical analysis was performed using correlation coecients and the unpaired Student's t-test for measured data and the w 2 test for categorical data. Patient groups were compared using the w 2 test or Mann-Whitney test. The disease-free survival curves for patient groups were calculated by the Kaplan-Meier method, and were compared using the log-rank test. Cox's proportional hazards model was used for the univariate and multivariate analyses. P values less than 0.05 were considered to indicate statistical signi®cance.
